Sign in

CIK 0000921299

  • Non-accelerated filer
  • Smaller reporting company

KYNTRA BIO, INC.

Sign in to watch
Ticker
KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770357827
Phone
+1 415-978-1200
Business address
350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
Former names
FIBROGEN INC
  1. 4 Shares withheld for taxes CEO gave up 494 shares (to pay taxes)
  2. 4 Open-market buy Director bought 23,567 shares at $5.07 ($119,485)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy CEO bought 145,000 shares at $0.35 ($50,663)
  9. 4 Open-market buy Director bought 300,000 shares at an average $0.35 ($105,040)
  10. 4 Shares withheld for taxes CEO gave up 22,405 shares (to pay taxes)
  11. 4 Shares withheld for taxes SVP, CHINA OPERATIONS gave up 7,430 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Financial Officer gave up 2,325 shares (to pay taxes)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 2,512 shares (to pay taxes)
  17. 4 Shares withheld for taxes CEO gave up 2,363 shares (to pay taxes)
  18. 4 Shares withheld for taxes SVP, CHINA OPERATIONS gave up 2,792 shares (to pay taxes)
  19. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 17,115 shares (to pay taxes)
  20. 4 Shares withheld for taxes CEO gave up 2,363 shares (to pay taxes)

Page 2 of 38 · 759 filings